Latest News & Features
Refine Search
Americas
The governor of California, Jerry Brown, has refused to sign legislation seeking to introduce changes to the state’s pharmacy law on biosimilars. 29 October 2013
Asia
A court appeal by Bayer against India’s first ever compulsory licence on its patented cancer drug will start today, October 29. 29 October 2013
Big Pharma
Mr Justice Arnold has refused to recuse himself from a patent trial after he was accused of being conflicted by an expert witness. 28 October 2013
article
The US District Court for the District of Arizona has rejected technology company W.L. Gore’s motion for a new trial to amend the judgment of its patent dispute with medical device maker C.R. Bard. 24 October 2013
article
British barrister Richard Hacon is set to become the permanent presiding judge of the Intellectual Property Enterprise Court, multiple sources have told WIPR. 22 October 2013
Big Pharma
UK-based pharmaceutical company AstraZeneca announced on October 15 that its biologics R&D subsidiary MedImmune had acquired cancer drug maker Spirogen. 18 October 2013
Biotechnology
When the US Supreme Court decided in favour of Monsanto in its case against a soybean farmer, it clarified the patent status of certain self-replicating technologies. In Europe, the result would probably have been the same, say Steven Zeman and Heike Vogelsang-Wenke. 16 October 2013
Asia
LSIPR spoke to Jörg Thomaier, chief IP counsel at Bayer, about the state of protection in emerging jurisdictions and the challenges the global company faces in asserting its IP across the world. 16 October 2013
Biotechnology
The Court of Justice of the European Union’s decision in the Brüstle case has worrying implications for some stem cell patents. Andy Sanderson looks at the landscape across Europe. 16 October 2013
Americas
New guidelines for the examination of biotechnology inventions in Brazil provide useful support for applicants, as Gabriel Di Blasi and Alexandre Santos explain. 16 October 2013